Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2010, Article ID 192543, 8 pages
http://dx.doi.org/10.1155/2010/192543
Review Article

Toll-Like Receptor Signaling and Liver Fibrosis

1Division of Gastroenterology, Department of Medicine, School of Medicine, University of California San Diego, 9500 Gilman Drive MC# 0702, Leichtag Biomedical Research Building Rm# 332 MM, La Jolla, CA 92093-0702, USA
2Department of Internal Medicine, College of Medicine, Yonsei University, Seoul 135-720, Republic of Korea

Received 24 March 2010; Accepted 16 June 2010

Academic Editor: Ian Nicholas Crispe

Copyright © 2010 Tomonori Aoyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [85 citations]

The following is the list of published articles that have cited the current article.

  • Ekihiro Seki, EekJoong Park, and Jiro Fujimoto, “Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis,” Hepatology Research, vol. 41, no. 7, pp. 597–610, 2011. View at Publisher · View at Google Scholar
  • Isabelle E. Vincent, Claudia Zannetti, Julie Lucifora, Helene Norder, Ulrike Protzer, Pierre Hainaut, Fabien Zoulim, Massimo Tommasino, Christian Trépo, Uzma Hasan, and Isabelle Chemin, “Hepatitis b virus impairs tlr9 expression and function in plasmacytoid dendritic cells,” PLoS ONE, vol. 6, no. 10, 2011. View at Publisher · View at Google Scholar
  • M. W. Lawless, and C. M. Greene, “Toll-like receptor signalling in liver disease: ER stress the missing link?,” Cytokine, vol. 59, no. 2, pp. 195–202, 2012. View at Publisher · View at Google Scholar
  • Yaron Ilan, “Leaky gut and the liver: A role for bacterial transllocation in nonalcoholic steatohepatitis,” World Journal Of Gastroenterology, vol. 18, no. 21, pp. 2609–2618, 2012. View at Publisher · View at Google Scholar
  • Falk A. Gonnert, Elke Kunisch, Mieczyslaw Gajda, Sandro Lambeck, Martina Weber, Ralf A. Claus, Michael Bauer, and Raimund W. Kinne, “Hepatic Fibrosis In A Long-Term Murine Model Of Sepsis,” Shock, vol. 37, no. 4, pp. 399–407, 2012. View at Publisher · View at Google Scholar
  • Maria C. Guido, Carolina F. Clemente, Ana I. Moretti, Hermes V. Barbeiro, Victor Debbas, Elia G. Caldini, Kleber G. Franchini, and Francisco G. Soriano, “Small Interfering Rna Targeting Focal Adhesion Kinase Prevents Cardiac Dysfunction In Endotoxemia,” Shock, vol. 37, no. 1, pp. 77–84, 2012. View at Publisher · View at Google Scholar
  • Min Cong, Keiko Iwaisako, Chunyan Jiang, and Tatiana Kisseleva, “Cell Signals Influencing Hepatic Fibrosis,” International Journal of Hepatology, vol. 2012, pp. 1–18, 2012. View at Publisher · View at Google Scholar
  • Praveen Guturu, and Andrea Duchini, “Etiopathogenesis of Nonalcoholic Steatohepatitis: Role of Obesity, Insulin Resistance and Mechanisms of Hepatotoxicity,” International Journal of Hepatology, vol. 2012, pp. 1–8, 2012. View at Publisher · View at Google Scholar
  • Robert Lafyatis, and Alessandra Farina, “New insights into the mechanisms of innate immune receptor signalling in fibrosis,” Open Rheumatology Journal, vol. 6, no. 1, pp. 72–79, 2012. View at Publisher · View at Google Scholar
  • Michael S. Stewart, Margaret J.R. Heerwagen, and Jacob E. Friedman, “Developmental programming of pediatric nonalcoholic fatty liver disease: Redefining the first hit,” Clinical Obstetrics and Gynecology, vol. 56, no. 3, pp. 577–590, 2013. View at Publisher · View at Google Scholar
  • Walter Gottlieb Land, “Chronic allograft dysfunction: A model disorder of innate immunity,” Biomedical Journal, vol. 36, no. 5, pp. 209–228, 2013. View at Publisher · View at Google Scholar
  • Giuseppe Fabio Parisi, Giovanna Di Dio, Chiara Franzonello, Alessia Gennaro, Novella Rotolo, and Elena Lionetti, “Liver Disease in Cystic Fibrosis: an Update,” Hepatitis Monthly, vol. 13, no. 8, 2013. View at Publisher · View at Google Scholar
  • Haitao Shi, Lei Dong, Xiaoyan Dang, Yaping Liu, Jiong Jiang, Yan Wang, Xiaolan Lu, and Xiaoyan Guo, “Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells,” Inflammation Research, vol. 62, no. 6, pp. 581–587, 2013. View at Publisher · View at Google Scholar
  • Veerle Bieghs, and Christian Trautwein, “The innate immune response during liver inflammation and metabolic disease,” Trends in Immunology, 2013. View at Publisher · View at Google Scholar
  • Thomas Flass, and Michael R. Narkewicz, “Cirrhosis and other liver disease in cystic fibrosis,” Journal of Cystic Fibrosis, vol. 12, no. 2, pp. 116–124, 2013. View at Publisher · View at Google Scholar
  • J. Aron-Wisnewsky, B. Gaborit, A. Dutour, and K. Clement, “Gut microbiota and non-alcoholic fatty liver disease: new insights,” Clinical Microbiology and Infection, vol. 19, no. 4, pp. 338–348, 2013. View at Publisher · View at Google Scholar
  • Yinglin Liu, Carol R. Gardner, Jeffrey D. Laskin, and Debra L. Laskin, “Classical and alternative activation of rat hepatic sinusoidal endothelial cells by inflammatory stimuli,” Experimental and Molecular Pathology, vol. 94, no. 1, pp. 160–167, 2013. View at Publisher · View at Google Scholar
  • Yinglin Liu, Carol R. Gardner, Jeffrey D. Laskin, and Debra L. Laskin, “Classical and alternative activation of rat hepatic sinusoidal endothelial cells by inflammatory stimuli,” Experimental And Molecular Pathology, vol. 94, no. 1, pp. 160–167, 2013. View at Publisher · View at Google Scholar
  • Lina Abu-Tair, Jonathan H. Axelrod, Sarit Doron, Yossi Ovadya, Valery Krizhanovsky, Eithan Galun, Johnny Amer, and Rifaat Safadi, “Natural Killer Cell-Dependent Anti-Fibrotic Pathway in Liver Injury via Toll-Like Receptor-9,” Plos One, vol. 8, no. 12, 2013. View at Publisher · View at Google Scholar
  • Ed Wilkins, Mark Nelson, Kosh Agarwal, Dola Awoyemi, Eleanor Barnes, Sanjay Bhagani, Gary Brook, Ashley Brown, Sheena Castelino, Graham Cooke, Martin Fisher, Anna Maria Geretti, Robert James, Ranjababu Kulasegaram, Clifford Leen, David Mutimer, Chloe Orkin, Emma Page, Adrian Palfreeman, Padmasayee Papineni, Alison Rodger, and C. Y. William Tong, “British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013,” Hiv Medicine, vol. 14, pp. 1–71, 2013. View at Publisher · View at Google Scholar
  • Hans Dieter Nischalke, Cordula Berger, Philipp Lutz, Bettina Langhans, Franziska Wolter, Marianne Eisenhardt, Benjamin Kraemer, Pavlos Kokordelis, Andreas Glaessner, Tobias Mueller, Jonas Rosendahl, Janett Fischer, Thomas Berg, Frank Gruenhage, Ludger Leifeld, Michael Soyka, Jacob Nattermann, Tilman Sauerbruch, Felix Stickel, and Ulrich Spengler, “Influence of the CXCL1 rs4074 A Allele on Alcohol Induced Cirrhosis and HCC in Patients of European Descent,” Plos One, vol. 8, no. 11, 2013. View at Publisher · View at Google Scholar
  • Maya Gulubova, Irena Manolova, Julian Ananiev, Dobroslav Kjurkchiev, Alexander Julianov, and Iskra Altunkova, “Relationship of TGF-beta 1 and Smad7 expression with decreased dendritic cell infiltration in liver gastrointestinal cancer metastasis,” Apmis, vol. 121, no. 10, pp. 967–975, 2013. View at Publisher · View at Google Scholar
  • Jessica Brownell, Jessica Wagoner, Erica S. Lovelace, Derek Thirstrup, Isaac Mohar, Wesley Smith, Silvia Giugliano, Kui Li, I. Nicholas Crispe, Hugo R. Rosen, and Stephen J. Polyak, “Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes,” Journal of Hepatology, vol. 59, no. 4, pp. 701–708, 2013. View at Publisher · View at Google Scholar
  • Haitao Shi, Lei Dong, Jiong Jiang, Juhui Zhao, Gang Zhao, Xiaoyan Dang, Xiaolan Lu, and Miao Jia, “Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway,” Toxicology, vol. 303, pp. 107–114, 2013. View at Publisher · View at Google Scholar
  • Hisako Furusho, Mutsumi Miyauchi, Hideyuki Hyogo, Toshihiro Inubushi, Min Ao, Kazuhisa Ouhara, Junzou Hisatune, Hidemi Kurihara, Motoyuki Sugai, C. Nelson Hayes, Takashi Nakahara, Hiroshi Aikata, Shoichi Takahashi, Kazuaki Chayama, and Takashi Takata, “Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice,” Journal of Gastroenterology, 2013. View at Publisher · View at Google Scholar
  • Jan Petrasek, Timea Csak, and Gyongyi Szabo, “Toll-Like Receptors in Liver Disease,” Advances in Clinical Chemistry, Vol 59, vol. 59, pp. 155–201, 2013. View at Publisher · View at Google Scholar
  • Stephen J. Polyak, Derek Thirstrup, Wesley Smith, Hugo R. Rosen, Isaac Mohar, Jessica Brownell, I. Nicholas Crispe, Jessica Wagoner, Erica S. Lovelace, Silvia Giugliano, and Kui Li, “Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes,” Journal Of Hepatology, vol. 59, no. 4, pp. 701–708, 2013. View at Publisher · View at Google Scholar
  • Leila Gobejishvili, Shirish Barve, Katja Breitkopf-Heinlein, JingWen Zhang, Steven Dooley, Craig J. McClain, Yan Li, and Diana V. Avila, “Rolipram Attenuates Bile Duct Ligation-Induced Liver Injury in Rats: A Potential Pathogenic Role of PDE4,” Journal Of Pharmacology And Experimental Therapeutics, vol. 347, no. 1, pp. 80–90, 2013. View at Publisher · View at Google Scholar
  • Anna Mania, Mariusz Kaczmarek, Iwona Mozer-Lisewska, Arleta Kowala-Piaskowska, Agata Kolecka-Bednarczyk, Magdalena Frydrychowicz, Bartosz Brzezicha, Rifaat Safadi, Anna Pauli, Husam Samara, and Jan Zeromski, “Hepatic stellate cells (HSC) cell line (LX-2) and Toll-like receptors - phenotypic/mRNA expression and in vitro functional studies,” Central European Journal of Immunology, vol. 38, no. 4, pp. 486–493, 2013. View at Publisher · View at Google Scholar
  • Mohammad Zare-Bidaki, Kyoko Tsukiyama-Kohara, and Mohammad Kazemi Arababadi, “Toll-Like Receptor 4 and Hepatitis B Infection: Molecular Mechanisms and Pathogenesis,” Viral Immunology, vol. 27, no. 7, pp. 321–326, 2014. View at Publisher · View at Google Scholar
  • Isabelle K. Vila, Pierre-Marie Badin, Marie-Adeline Marques, Laurent Monbrun, Corinne Lefort, Lucile Mir, Katie Louche, Virginie Bourlier, Balbine Roussel, Philippe Gui, Jacques Grober, Vladimír Štich, Lenka Rossmeislová, Alexia Zakaroff-Girard, Anne Bouloumié, Nathalie Viguerie, Cedric Moro, Geneviève Tavernier, and Dominique Langin, “Immune Cell Toll-like Receptor 4 Mediates the Development of Obesity- and Endotoxemia-Associated Adipose Tissue Fibrosis,” Cell Reports, 2014. View at Publisher · View at Google Scholar
  • Patricia E. Molina, Jason D. Gardner, Flavia M. Souza-Smith, and Annie M. Whitaker, “Alcohol Abuse: Critical Pathophysiological Processes and Contribution to Disease Burden,” Physiology, vol. 29, no. 3, pp. 203–215, 2014. View at Publisher · View at Google Scholar
  • Rosaria Meli, Giuseppina Mattace Raso, and Antonio Calignano, “Role of Innate Immune Response in Non-Alcoholic Fatty Liver Disease: Metabolic Complications and Therapeutic Tools,” Frontiers in Immunology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Nora Sipeki, Peter Antal-Szalmas, and Peter L. Lakatos, “Immune dysfunction in cirrhosis,” World Journal of Gastroenterology, vol. 20, no. 10, pp. 2564–2577, 2014. View at Publisher · View at Google Scholar
  • Hui Qian, Jian Shi, Ting-Ting Fan, Jiao Lv, Si-Wen Chen, Chun-Yan Song, Zhi-Wu Zheng, Wei-Fen Xie, and Yue-Xiang Chen, “Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats,” World Journal of Gastroenterology, vol. 20, no. 7, pp. 1822–1832, 2014. View at Publisher · View at Google Scholar
  • N. Moriya, H. Kataoka, H. Fujino, J. Nishikawa, and F. Kugawa, “Different expression patterns of hepatic cytochrome P450 s during anaphylactic or lipopolysaccharide-induced inflammation,” Pharmazie, vol. 69, no. 2, pp. 142–147, 2014. View at Publisher · View at Google Scholar
  • Joseph A. Odin, “Toll-like receptors and liver disease,” Liver International, vol. 34, no. 2, pp. 184–196, 2014. View at Publisher · View at Google Scholar
  • Silvia M. Ferolla, Geyza N. A. Armiliato, Claudia A. Couto, and Teresa C. A. Ferrari, “The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease,” Nutrients, vol. 6, no. 12, pp. 5583–5599, 2014. View at Publisher · View at Google Scholar
  • Veerle Bieghs, and Christian Trautwein, “Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.,” Hepatobiliary surgery and nutrition, vol. 3, no. 6, pp. 377–85, 2014. View at Publisher · View at Google Scholar
  • Nur Arslan, “Obesity, fatty liver disease and intestinal microbiota,” World Journal Of Gastroenterology, vol. 20, no. 44, pp. 16452–16463, 2014. View at Publisher · View at Google Scholar
  • Nur Arslan, “Obesity, fatty liver disease and intestinal microbiota,” World Journal of Gastroenterology, vol. 20, no. 44, pp. 16452–16463, 2014. View at Publisher · View at Google Scholar
  • Francisco Garcia Soriano, Maria Carolina Guido, Hermes Vieira Barbeiro, Elia Garcia Caldini, Clara Batista Lorigados, and Antonio Carlos Nogueira, “Endotoxemic Myocardial Dysfunction,” Shock, vol. 42, no. 5, pp. 472–479, 2014. View at Publisher · View at Google Scholar
  • Chia-Lin Wu, Hung-Ming Wu, Ping-Fang Chiu, Hung-Hsiang Liou, Chirn-Bin Chang, Der-Cherng Tarng, and Chia-Chu Chang, “Associations between the Duration of Dialysis, Endotoxemia, Monocyte Chemoattractant Protein-1, and the Effects of a Short-Dwell Exchange in Patients Requiring Continuous Ambulatory Peritoneal Dialysis,” Plos One, vol. 9, no. 10, 2014. View at Publisher · View at Google Scholar
  • S. Affo, O. Morales-Ibanez, D. Rodrigo-Torres, J. Altamirano, D. Blaya, D. H. Dapito, C. Millan, M. Coll, J. M. Caviglia, V. Arroyo, J. Caballeria, R. F. Schwabe, P. Gines, R. Bataller, and P. Sancho-Bru, “CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis,” Gut, vol. 63, no. 11, pp. 1782–1792, 2014. View at Publisher · View at Google Scholar
  • Martine Fanton d'Andon, Nathalie Quellard, Beatrice Fernandez, Gwenn Ratet, Sonia Lacroix-Lamande, Alain Vandewalle, Ivo G. Boneca, Jean-Michel Goujon, and Catherine Werts, “Leptospira Interrogans Induces Fibrosis in the Mouse Kidney through Inos-Dependent, TLR- and NLR-Independent Signaling Pathways,” Plos Neglected Tropical Diseases, vol. 8, no. 1, 2014. View at Publisher · View at Google Scholar
  • Yong-Han Paik, Jonghwa Kim, Tomonori Aoyama, Samuele De Minicis, Ramon Bataller, and David A. Brenner, “Role of NADPH Oxidases in Liver Fibrosis,” Antioxidants & Redox Signaling, pp. 140124063649002, 2014. View at Publisher · View at Google Scholar
  • Vaishali Patel, and Arun J. Sanyalpp. 345–359, 2014. View at Publisher · View at Google Scholar
  • Maria A. Selim, Eda K. Holl, Tosan Ehanire, Bruce Sullenger, Howard Levinson, and Jennifer E. Bond, “The nucleic acid scavenger polyamidoamine third-generation dendrimer inhibits fibroblast activation and granulation tissue contraction,” Plastic and Reconstructive Surgery, vol. 134, no. 3, 2014. View at Publisher · View at Google Scholar
  • Giuseppina Stifano, Alsya J. Affandi, Allison L. Mathes, Lisa M. Rice, Sashidhar Nakerakanti, Banafsheh Nazari, Jungeun Lee, Romy B. Christmann, and Robert Lafyatis, “Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expressio,” Arthritis Research & Therapy, vol. 16, no. 4, 2014. View at Publisher · View at Google Scholar
  • Tristan I. Evans, Haiying Li, Jamie L. Schafer, Nichole R. Klatt, Xing-Pei Hao, Ryan P. Traslavina, Jacob D. Estes, Jason M. Brenchley, and R. Keith Reeves, “SIV-induced Translocation of Bacterial Products in the Liver Mobilizes Myeloid Dendritic and Natural Killer Cells Associated With Liver Damage,” Journal of Infectious Diseases, pp. jiv404, 2015. View at Publisher · View at Google Scholar
  • Qin Chen, Shi-Zhong Zheng, Lian-Yun Chen, Huan-Huan Jin, Feng Zhang, and Yin Lu, “Role of dendritic cells in hepatic fibrosis,” Chinese Pharmacological Bulletin, vol. 31, no. 8, pp. 1053–1056, 2015. View at Publisher · View at Google Scholar
  • Tian Lan, Tatiana Kisseleva, and David A. Brenner, “Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation,” Plos One, vol. 10, no. 7, 2015. View at Publisher · View at Google Scholar
  • Judith Aron-Wisnewsky, and Jean-Louis Pepin, “New insights in the pathophysiology of chronic intermittent hypoxia-induced NASH: the role of gut–liver axis impairment: Figure 1,” Thorax, vol. 70, no. 8, pp. 713–715, 2015. View at Publisher · View at Google Scholar
  • Thomas Flass, Suhong Tong, Daniel N. Frank, Brandie D. Wagner, Charles E. Robertson, Cassandra Vogel Kotter, Ronald J. Sokol, Edith Zemanick, Frank Accurso, Edward J. Hoffenberg, and Michael R. Narkewicz, “Intestinal Lesions Are Associated with Altered Intestinal Microbiome and Are More Frequent in Children and Young Adults with Cystic Fibrosis and Cirrh,” Plos One, vol. 10, no. 2, 2015. View at Publisher · View at Google Scholar
  • Lena Seifert, Michael Deutsch, Sara Alothman, Dalia Alqunaibit, Gregor Werba, Mridul Pansari, Matthew Pergamo, Atsuo Ochi, Alejandro Torres-Hernandez, Elliot Levie, Daniel Tippens, Stephanie H. Greco, Shaun Tiwari, Nancy Ngoc Giao Ly, Andrew Eisenthal, Eliza van Heerden, Antonina Avanzi, Rocky Barilla, Constantinos P. Zambirinis, Mauricio Rendon, Donnele Daley, H. Leon Pachter, Cristina Hajdu, and George Miller, “Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways,” Cell Reports, 2015. View at Publisher · View at Google Scholar
  • Sofia B. Leite, Tiffany Roosens, Adil El Taghdouini, Inge Mannaerts, Ayla J. Smout, Mustapha Najimi, Etienne Sokal, Fozia Noor, Christophe Chesne, and Leo A. van Grunsven, “Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro,” Biomaterials, 2015. View at Publisher · View at Google Scholar
  • Makoto Usami, Makoto Miyoshi, and Hayato Yamashita, “Gut microbiota and host metabolism in liver cirrhosis,” World Journal Of Gastroenterology, vol. 21, no. 41, pp. 11597–11608, 2015. View at Publisher · View at Google Scholar
  • Melisa Dirchwolf, and Andrés Eduardo Ruf, “Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis,” World Journal of Hepatology, vol. 7, no. 16, pp. 1974–1981, 2015. View at Publisher · View at Google Scholar
  • Jing Yang, Min Li, and Qi Chang Zheng, “Emerging role of Toll-like receptor 4 in hepatocellular carcinoma.,” Journal of hepatocellular carcinoma, vol. 2, pp. 11–7, 2015. View at Publisher · View at Google Scholar
  • Mizuki Kuramochi, Takeshi Izawa, Munmun Pervin, Alexandra Bondoc, Mitsuru Kuwamura, and Jyoji Yamate, “The kinetics of damage-associated molecular patterns (DAMPs) and toll-like receptors during thioacetamide-induced acute liver injury in rats,” Experimental and Toxicologic Pathology, 2016. View at Publisher · View at Google Scholar
  • Yuhan Chen, Zhaochong Zeng, Xiaoyun Shen, Zhifeng Wu, Yinying Dong, and Jason Cheng, “MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways,” International Journal of Molecular Sciences, vol. 17, no. 7, pp. 1076, 2016. View at Publisher · View at Google Scholar
  • Silvia Ferolla, Cláudia Couto, Luciana Costa-Silva, Geyza Armiliato, Cristiano Pereira, Flaviano Martins, Maria Ferrari, Eduardo Vilela, Henrique Torres, Aloísio Cunha, and Teresa Ferrari, “Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis,” Nutrients, vol. 8, no. 7, pp. 397, 2016. View at Publisher · View at Google Scholar
  • Xiaolin Ren, Minggai Ge, Xiaofeng Qin, Peng Xu, Pingya Zhu, Yongyan Dang, Jun Gu, and Xiyun Ye, “S100a8/NF-κB signal pathway is involved in the 800-nm diode laser-induced skin collagen remodeling.,” Lasers in medical science, vol. 31, no. 4, pp. 673–8, 2016. View at Publisher · View at Google Scholar
  • Jinghua Du, Xuemin Niu, Rongqi Wang, Suxian Zhao, Lingbo Kong, Yuguo Zhang, and Yuemin Nan, “TLR4-dependent signaling pathway modulation: A novel mechanism by which pioglitazone protects against nutritional fibrotic steatohepatitis in mice,” Molecular Medicine Reports, vol. 13, no. 3, pp. 2159–2166, 2016. View at Publisher · View at Google Scholar
  • Shuang Liang, Tatiana Kisseleva, and David A. Brenner, “The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts,” Frontiers in Physiology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Takeru Amiya, Nobuhiro Nakamoto, Po-sung Chu, Toshiaki Teratani, Hideaki Nakajima, Yumi Fukuchi, Nobuhito Taniki, Akihiro Yamaguchi, Shunsuke Shiba, Rei Miyake, Tadashi Katayama, Hirotoshi Ebinuma, and Takanori Kanai, “Bone marrow-derived macrophages distinct from tissue-resident macrophages play a pivotal role in Concanavalin A-induced murine liver injury via CCR9 axis,” Scientific Reports, vol. 6, no. 1, 2016. View at Publisher · View at Google Scholar
  • Starostina, Meledina, Shipunov, Chernykh, Ostanin, Leplina, and Shevela, “Spontaneous and LPS-induced production of 26 cytokines secreted by blood cells of patients with liver cirrhosis during of cell therapy,” Medical Immunology (Russia), vol. 18, no. 1, pp. 63–78, 2016. View at Publisher · View at Google Scholar
  • Safak Kiziltas, “Toll-like receptors in pathophysiology of liver diseases,” World Journal of Hepatology, vol. 8, no. 32, pp. 1354–1369, 2016. View at Publisher · View at Google Scholar
  • Damian Piotrowski, and Anna Boroń-Kaczmarska, “Bacterial infections and hepatic encephalopathy in liver cirrhosis–prophylaxis and treatment,” Advances in Medical Sciences, vol. 62, no. 2, pp. 345–356, 2017. View at Publisher · View at Google Scholar
  • Naoaki Morihara, Atsuko Hino, Satomi Miki, Miyuki Takashima, and Jun-ichiro Suzuki, “Aged garlic extract suppresses inflammation in apolipoprotein E-knockout mice,” Molecular Nutrition & Food Research, pp. 1700308, 2017. View at Publisher · View at Google Scholar
  • Ying-Hsien Kao, Po-Han Chen, Tin-Ya Wu, Yu-Chun Lin, Ming-Shian Tsai, Po-Huang Lee, Tzong-Shyuan Tai, Huoy-Rou Chang, and Cheuk-Kwan Sun, “Lipopolysaccharides induce Smad2 phosphorylation through PI3K/Akt and MAPK cascades in HSC-T6 hepatic stellate cells,” Life Sciences, 2017. View at Publisher · View at Google Scholar
  • Katherine J. Brempelis, Sebastian Y. Yuen, Nicole Schwarz, Isaac Mohar, and Ian N. Crispe, “Central role of the TIR-domain-containing adaptor-inducing interferon-β (TRIF) adaptor protein in murine sterile liver injury,” Hepatology, 2017. View at Publisher · View at Google Scholar
  • Chathur Acharya, and Jasmohan S. Bajaj, “Gut Microbiota and Complications of Liver Disease,” Gastroenterology Clinics of North America, vol. 46, no. 1, pp. 155–169, 2017. View at Publisher · View at Google Scholar
  • Mohd Talha Noor, and Piyush Manoria, “Immune Dysfunction in Cirrhosis,” Journal of Clinical and Translational Hepatology, vol. XX, no. XX, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Zhencheng Wen, Xiaofang Ji, Juanjuan Tang, Guiying Lin, Linzhuo Xiao, Cuiying Liang, Manni Wang, Fang Su, Dominique Ferrandon, and Zi Li, “Positive Feedback Regulation between Transglutaminase 2 and Toll-Like Receptor 4 Signaling in Hepatic Stellate Cells Correlates with Liver Fibrosis Post Schistosoma japonicum Infection,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Chathur Acharya, Sinem Esra Sahingur, and Jasmohan S. Bajaj, “Microbiota, cirrhosis, and the emerging oral-gut-liver axis,” JCI Insight, vol. 2, no. 19, 2017. View at Publisher · View at Google Scholar
  • Haowen Jiang, Kangsen Mai, Fuyun Bian, Mingsan Man, Huihui Zhou, Wei Xu, and Gen He, “Dietary gossypol suppressed postprandial TOR signaling and elevated ER stress pathways in turbot (Scophthalmus maximus L.),” American Journal of Physiology - Endocrinology and Metabolism, vol. 312, no. 1, pp. E37–E47, 2017. View at Publisher · View at Google Scholar
  • Thais Ortiz Hammes, Renata Leke, Thayssa Dalla Costa Escobar, Fabiola Schons Meyer, Themis Reverbel da Silveira, Laisa Beduschi Fracasso, and Michael Éverton Andrades, “Lactobacillus rhamnosus GG reduces hepatic fibrosis in a model of chronic liver disease in rats,” Nutricion Hospitalaria, vol. 34, no. 3, pp. 702–709, 2017. View at Publisher · View at Google Scholar
  • John J. Lemasters, and Zhi Zhong, “Mitophagy in hepatocytes: Types, initiators and role in adaptive ethanol metabolism,” Liver Research, 2018. View at Publisher · View at Google Scholar
  • Zhi Zhong, and John J. Lemasters, “A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease,” Alcoholism: Clinical and Experimental Research, 2018. View at Publisher · View at Google Scholar
  • Brett R Loman, Diego Hernández-Saavedra, Ruopeng An, and R Scott Rector, “Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis,” Nutrition Reviews, 2018. View at Publisher · View at Google Scholar
  • Banrida Wahlang, Craig McClain, Shirish Barve, and Leila Gobejishvili, “Role of cAMP and phosphodiesterase signaling in liver health and disease,” Cellular Signalling, 2018. View at Publisher · View at Google Scholar
  • Xinrui Xing, Si Chen, Ling Li, Yan Cao, Langdong Chen, Xiaobo Wang, and Zhenyu Zhu, “The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability – A Network Pharmacology and Transcriptomics Approach,” Frontiers in Pharmacology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Fengyan Cao, Yunfang Zhang, Weiguang Li, Kuniyoshi Shimizu, Haifeng Xie, and Chaofeng Zhang, “Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways,” International Immunopharmacology, vol. 55, pp. 183–192, 2018. View at Publisher · View at Google Scholar
  • Katherine J. P. Schwenger, Colin M. Bolzon, Carrie Li, and Johane P. Allard, “Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria,” European Journal of Nutrition, 2018. View at Publisher · View at Google Scholar